Orientin inhibits cyclin E/cyclin A-CDK2 to induce growth arrest at senescence in human gastric cancer cells
Food and Chemical Toxicology · 2026-09 · 215 · 116227
DOI: 10.1016/j.fct.2026.116227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2026-09. Verfasst von Yang Yan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Yantai Yantaishan Hospital, Yantai, Shandong, China. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinase 2, Stomach Neoplasms, Cyclin E, Cellular Senescence. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Gastric cancer (GC) is a primary epithelial malignancy originating in the stomach. This research explored the influence and mechanism of Orientin on cellular senescence in GC. Orientin was predicted to regulate multiple cell cycle-related pathways, including cyclin-dependent protein kinase activity. Orientin docked with cyclin dependent kinase 2 (CDK2), cyclin A2 (CCNA2), cyclin E1 (CCNE1), and cyclin E2 (CCNE2) with binding energies of -9.1, -7.5, -7.2, and -8.3 kcal/mol, respectively. The IC50 values of Orientin for AGS and HGC-27 cells were 24.33 μM and 39.28 μM, respectively. Orientin dose-dependently inhibited GC cell proliferation, promoted G0/G1 phase arrest, as well as downregulated CDK2, CCNA2, CCNE1, and CCNE2 expression. It enhanced senescence-associated β-galactosidase staining intensity, upregulated p16 and p21, and downregulated phosphorylated retinoblastoma (p-Rb). In vivo, Orientin also suppressed tumor progression, promoted p16 and p21 expression, and inhibited CCNE/CCNA-CDK2 signaling. Orientin exerts anti-cancer effects in GC through triggering cellular senescence and cell cycle arrest, likely via activating p16/p21-Rb signaling axis and inhibiting the CCNE/CCNA-CDK2 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Yantai Yantaishan Hospital, Yantai, Shandong, China.
- Department of Radiation Oncology, Yantai Yantaishan Hospital, Yantai, Shandong, China. Electronic address: guyongfei1986@163.com.
Zitieren
APA
Yan, Y., & Gu, Y. (2026). Orientin inhibits cyclin E/cyclin A-CDK2 to induce growth arrest at senescence in human gastric cancer cells. Food and Chemical Toxicology, 215, 116227. https://doi.org/10.1016/j.fct.2026.116227
Vancouver
Yan Y, Gu Y. Orientin inhibits cyclin E/cyclin A-CDK2 to induce growth arrest at senescence in human gastric cancer cells. Food and Chemical Toxicology. 2026;215:116227. doi:10.1016/j.fct.2026.116227
BibTeX
@article{Yan2026,
author = {Yan, Yang and Gu, Yongfei},
title = {Orientin inhibits cyclin E/cyclin A-CDK2 to induce growth arrest at senescence in human gastric cancer cells},
journal = {Food and Chemical Toxicology},
year = {2026},
volume = {215},
pages = {116227},
doi = {10.1016/j.fct.2026.116227}
}
EUVIMED